Keywords: astra/lexin, pharma, deal, lex032, evaluation, option, agreement

Astra/Lexin Pharma deal for LEX032

Article | 06 November 1995

Print This

- An evaluation and option agreement has been signed by Astra Merck Inc and Lexin Pharmaceuticals to test LEX032, Lexin's recombinant ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in